Skip to main content
Erschienen in: European Journal of Pediatrics 4/2022

10.01.2022 | Original Article

Comparison of diagnostic criteria for children with familial Mediterranean fever

verfasst von: Esra Nagehan Akyol Onder, Kudret Ebru Ozcan, Feride Iffet Sahin, Kaan Savas Gulleroglu, Esra Baskin

Erschienen in: European Journal of Pediatrics | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Abstract

Familial Mediterranean fever (FMF) is an autoinflammatory disease characterized by recurrent attacks of fever and serositis. Diagnosis is made according to clinical findings and supported by genetic analysis. The most commonly used adult diagnostic criteria are the Tel-Hashomer criteria. Pediatric criteria for FMF diagnosis were described in 2009, but their reliability should be supported by additional reports. In this study, we aimed to compare the pediatric criteria and the Tel-Hashomer and 2019 Eurofever/PRINTO classification criteria using our FMF cohort. A total of 113 patients diagnosed with FMF were included. Demographic features and laboratory findings were retrospectively collected from the patients’ files. The patients were evaluated with the Tel-Hashomer, pediatric and Eurofever/PRINTO classification criteria. At least two of five new pediatric criteria were as sensitive (89%) and specific (85%) as the Tel-Hashomer criteria (sensitivity 70%, specificity 96%). We also evaluated the Eurofever/PRINTO classification criteria using our cohort and found a sensitivity of 94% and specificity of 91%.
   Conclusion: Using pediatric criteria for the diagnosis of FMF in children is a feasible and simple approach that can diagnose the disease based on at least two criteria. Therefore, our study supports the use of pediatric criteria in FMF diagnosis of children. Our results also confirm that the Eurofever/PRINTO classification criteria can be successfully applied for the diagnosis of FMF due to their high sensitivity (94%) and specificity (91%).
What is Known:
• The FMF diagnosis is made according clinical findings and supported by genetic analysis.
• The use of adult diagnostic criteria in pediatric FMF patients is controversial since classical clinical presentation is often absent in children.
What is New:
• Our study supports both the use of pediatric criteria and Eurofever/PRINTO classification criteria in clinical practice.
Literatur
2.
Zurück zum Zitat Lidar M, Livneh A (2007) Familial Mediterranean fever: clinical, molecular and management advancements. Neth J Med 65:318–324PubMed Lidar M, Livneh A (2007) Familial Mediterranean fever: clinical, molecular and management advancements. Neth J Med 65:318–324PubMed
3.
Zurück zum Zitat Demirkaya E, Saglam C, Turker T et al (2016) Paediatric Rheumatology International Trials Organisations (PRINTO); Eurofever Project. Performance of Different Diagnostic Criteria for Familial Mediterranean Fever in Children with Periodic Fevers: Results from a Multicenter International Registry. J Rheumatol 43:154–160. https://doi.org/10.3899/jrheum.141249CrossRefPubMed Demirkaya E, Saglam C, Turker T et al (2016) Paediatric Rheumatology International Trials Organisations (PRINTO); Eurofever Project. Performance of Different Diagnostic Criteria for Familial Mediterranean Fever in Children with Periodic Fevers: Results from a Multicenter International Registry. J Rheumatol 43:154–160. https://​doi.​org/​10.​3899/​jrheum.​141249CrossRefPubMed
11.
Zurück zum Zitat Kondi A, Hentgen V, Piram M, Letierce A, Guillaume-Czitrom S, Koné-Paut I (2010) Validation of the new paediatric criteria for the diagnosis of familial Mediterrian fever: data from a mixed population of 100 children from the French reference centre for auto-inflammatory disorders. Rheumatology (Oxford) 49:2200–2203. https://doi.org/10.1093/rheumatology/keq252 Kondi A, Hentgen V, Piram M, Letierce A, Guillaume-Czitrom S, Koné-Paut I (2010) Validation of the new paediatric criteria for the diagnosis of familial Mediterrian fever: data from a mixed population of 100 children from the French reference centre for auto-inflammatory disorders. Rheumatology (Oxford) 49:2200–2203. https://​doi.​org/​10.​1093/​rheumatology/​keq252
15.
Zurück zum Zitat Aletaha D, Neogi T, Silman AJ et al (2010) Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581. https://doi.org/10.1002/art.27584 Aletaha D, Neogi T, Silman AJ et al (2010) Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581. https://​doi.​org/​10.​1002/​art.​27584
Metadaten
Titel
Comparison of diagnostic criteria for children with familial Mediterranean fever
verfasst von
Esra Nagehan Akyol Onder
Kudret Ebru Ozcan
Feride Iffet Sahin
Kaan Savas Gulleroglu
Esra Baskin
Publikationsdatum
10.01.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Pediatrics / Ausgabe 4/2022
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-021-04370-y

Weitere Artikel der Ausgabe 4/2022

European Journal of Pediatrics 4/2022 Zur Ausgabe

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.